Lixte-2.1

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameLixte-2.1
Drug Alias NameHDAC 1/2 inhibitor (Lixte)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 2 inhibitorsHistone deacetylase 1 inhibitors
TargetsHistone deacetylase 2Histone deacetylase 1
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLixte Biotechnology Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLixte Biotechnology Holdings Inc
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A